FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Denies Metacel Ozobax Petition

FDA denies a Metacel petition asking the agency to require flavoring tests for generic forms of the companys Ozobax.

latest-news-card-1
Human Drugs

ICH Model-Informed Drug Development Guide Out

FDA publishes a draft International Council for Harmonization M15 guidance on model-informed drug development principles.

latest-news-card-1
Medical Devices

Sepsis Risk Assessment Test Gets Breakthrough Status

FDA grants MeMed a breakthrough device designation for its MeMed Severity test, intended for use in determining risk assessments in patients suspected...

latest-news-card-1
Human Drugs

Favorable Pirtobrutinib Data in Leukemia/Lymphoma: Lilly

Confirmatory data evaluating Eli Lillys pirtobrutinib in adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma meets its prim...

Medical Devices

FDA Clears 2 Pentax Endoscopes

FDA clears Pentax Medical 510(k)s for new endoscope models for colonoscopy and upper GI use.

latest-news-card-1
Federal Register

Guide on Standardized BIMO eSubmission Data

Federal Register notice: FDA makes available a guidance entitled Standardized Format for Electronic Submission of NDA and BLA Content for the Planning...

latest-news-card-1
Medical Devices

Update on Baxter Recall of Hemodialysis Transfer Sets

FDA updates a Baxter recall (device correction) of its MiniCap Extended Life PD Transfer Sets used in hemodialysis.

latest-news-card-1
Human Drugs

GSK Files for Nucala COPD Indication

FDA accepts for review a supplemental NDA for Nucala (mepolizumab) and its use as an add-on maintenance treatment for patients with chronic obstructiv...

latest-news-card-1
Human Drugs

Simplified Dosing for Cumberlands Acetadote OKd

FDA approves a Cumberland Pharmaceuticals supplemental NDA for a simplified dosing regimen of its Acetadote (N-acetylcysteine for injection).

latest-news-card-1
Human Drugs

Mixed Results on Keytruda Ovarian Cancer Study

Merck says a Phase 3 KEYLYNK-001 trial evaluating Keytruda (pembrolizumab) plus chemotherapy followed by maintenance with Lynparza (olaparib) met the...